The nomination committee is responsible for nominating the shareholder-elected members of the Board of Directors and make recommendations for remuneration to the members of the Boards of Directors.
Dr. Johan Christenson is a Partner of HealthCap. He received his medical training at the Karolinska Institute in Stockholm. Dr. Johan Christenson published his thesis in 1991 rendering him a PhD in basic neuroscience. He is the author of more than 25 scientific papers and articles. He served as a lecturer in Neuroscience. He held a position as assistant dean at the Karolinska Institute Graduate school for two years. He has four years of clinical specialist training in pediatrics and pediatric neurology. He has senior management experiencefrom Astra Pain Control as Project director and AstraZeneca as Global Product Director and member of the Pain Control therapy area management team. Prior to joining Health Cap he was with SEB Företagsinvest (the venture capital arm of SEB) to supervise the health care portfolio. He is currently a Board member of Cerenis SA, Oncos OY, Nexstim OY, Benechill Incand Trimb AB. He is a former director of several listed as well as unlisted biomedical companies including Algeta ASA, Orexo AB and Corevalve SA. Dr. Johan Christenson resides in Sweden.
Ole Peter Nordby
Ole Peter Nordby is an independent Life Science advisor. His previous positions have been Senior Portfolio Manager at Sigma Fondsforvaltning AS, Analyst at Handelsbanken Capital Markets, Investment director at NorgesInvestor and Senior Portfolio Manager at Vesta Fondsforvaltning. Mr. Nordby holds a MBA, Economics from BI Norwegian Business School, Master of Theology from University of Oslo and has been studying Molecular Biology at University of Oslo. Ole Peter Nordby is CEO at Idia AS and board member in Serodus, Pre Diagnostics and Norgesinvestor Formuesforvaltning. Ole Peter Nordby resides in Norway.
Olav Steinnes is the CFO of Inven2 AS, the technology transfer organization for the University of Oslo and Oslo University Hospital, Mr. Steinnes has extensive experience from the in-vitro diagnostics industry. He has held various management positions within finance, marketing and business development in companies like Nycomed ASA and Axis-Shield Plc. Mr. Steinnes holds an M.Sc in Business Administration from Norwegian School of Economics and Business Administration, NHH. Olav Steinnes resides in Norway.